Return to Listing

1 result(s) for

PI Name Protocol # Title
Eva Medvedova STUDY00017199 A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination with Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared with CyBorD Alone in Newly Diagnosed Systemic AL Amyloidosis
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080